Avalo Therapeutics (AVTX) FCF Margin Growth (1y) (2017 - 2025)
Avalo Therapeutics (AVTX) FCF Margin Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | -735,100.00 |
| Sep 30, 2024 | -173,271.00 |
| Dec 31, 2023 | -3,408.00 |
| Sep 30, 2023 | -293,529.00 |
| Jun 30, 2023 | -50,219.00 |
| Mar 31, 2023 | -77,974.00 |
| Dec 31, 2022 | 690,081.00 |
| Sep 30, 2022 | 139,194.00 |
| Jun 30, 2022 | -64,069.00 |
| Mar 31, 2022 | 250,701.00 |
| Dec 31, 2021 | -638,668.00 |
| Sep 30, 2021 | -28,485.00 |
| Jun 30, 2021 | 6,749.00 |
| Mar 31, 2021 | -366,836.00 |
| Dec 31, 2020 | -92,242.00 |
| Sep 30, 2020 | -72,223.00 |
| Jun 30, 2020 | -15,308.00 |
| Mar 31, 2020 | -8,078.00 |
| Dec 31, 2019 | -8,124.00 |